Preparation and immunological features of syngeneic monoclonal anti-idiotypic antibody using complementary determining region (CDR) peptide as the immunogen

被引:0
|
作者
Zhou, Y [1 ]
Hifumi, E [1 ]
Niimi, Y [1 ]
Uda, T [1 ]
机构
[1] Hiroshima Prefecture Univ, Dept Biosci, Shobara, Hiroshima 7270023, Japan
来源
LETTERS IN PEPTIDE SCIENCE | 2000年 / 7卷 / 05期
关键词
CDR; HIV; light chain; monoclonal idiotypic antibody;
D O I
10.1023/A:1011834919498
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A syngeneic monoclonal idiotypic antibody was prepared by immunizing the sequence peptide of complementary determining region-1 (CDRL-1) of 41S-2-L which is an antibody light chain capable of catalytically decomposing the antigen peptide (gp41 peptide:original antigen) as well as the intact gp41 molecule of HIV-1 envelope. The obtained idiotypic antibody, i41SL1-2, showed a high specificity to the CDRL-1 peptide. The intact i41SL1-2 and its heavy and light chains displayed apparent affinity constants to the CDRL-1 peptide of 3.6 x 10(9), 2.7 x 10(7), 1.8 x 10(6)/M, respectively. The i41SL1-2 recognized the artificial molecule CA2, which has a more complex steric conformation than the CDRL-1, while the i41SL1-2 showed very low affinity to the original monoclonal antibody 41S-2 and its light chain 41S-2-L. However, a homologous sequence, EGG-D, with the gp41 peptide was expressed in the complementary determining region-3 (CDRH-3) of the heavy chain of i41SL1-2. Furthermore, the consensus sequence EGG was located at the important position of the CDRH-3 loop of i41SL1-2. Although the sequence of CDRL-1 (16 mer) is quite shorter than that of whole light chain (112 mer), the CDRL-1 could induce the rearrangement of CDRH-3 gene of i41SL1-2 so as to express a homologous sequence with the original antigen.
引用
收藏
页码:299 / 310
页数:12
相关论文
共 21 条
  • [21] COMPARISON OF THE MOUSE ANTIBODY-RESPONSE TO DIFFERENT ANTIGENIC FORMULATIONS INCORPORATING A SYNTHETIC PEPTIDE REPRESENTING THE HEAVY-CHAIN 2ND COMPLEMENTARITY-DETERMINING REGION OF A MOUSE MONOCLONAL ANTI-CD4 ANTIBODY
    KANDA, P
    FRITZ, DA
    DUNHAM, RG
    SHULER, KR
    LOHMAN, KL
    KENNEDY, RC
    BUCK, D
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (08) : 1385 - 1385